Data protection Impressum

Life sciences

Since its Observer Country status since December 2015, Switzerland has participated in over 20 multinational clinical trials and infrastructure projects under the ECRIN banner, including platform trials on COVID-19.

European clinical research infrastructure bolstered as Switzerland becomes ECRIN member

5 July 2023

EBAMed's solution combines medical devices for proton therapy and motion tracking imaging and software to enable the treatment of patients in a non-invasive way, in a single out-patient session, whilst increasing 5-fold the patient throughput and saving costs.

EBAMed raises EUR 14.35 million to propel its groundbreaking cardiac radiation ablation therapy

4 July 2023

CSEM to establish a digital health research department in Bern

19 June 2023

Axe Santé, the canton of Valais’ center for sustainable health technologies

19 June 2023

Revolutionary mRNA vaccine against melanoma to be tested in Geneva

13 June 2023

Revolutionary breakthrough in prostate cancer treatment at the University of Bern

12 June 2023

Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey

12 June 2023

Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp

7 June 2023

NewBiologix pioneers breakthrough gene therapies with USD 50 million investment

16 May 2023

Novostia to launch first-in-human trials of its innovative artificial heart valve

8 May 2023

1 … 17 18 19 20 21 22 23 24 25 … 43